L Karlin - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

L Karlin

Showing results (41-50 of 44) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 44 results.

Nature|September 3, 2015

The spliceosome is a therapeutic vulnerability in MYC-driven cancerTiffany Y-T Hsu, Lukas M Simon, Nicholas J Neill, et al.

Cell|January 15, 2021

Spliceosome-targeted therapies trigger an antiviral immune response in triple-negative breast cancerElizabeth A Bowling, Jarey H Wang, Fade Gong, et al.

Cell Chemical Biology|October 21, 2020

Modulating Androgen Receptor-Driven Transcription in Prostate Cancer with Selective CDK9 InhibitorsAndré Richters, Shelby K Doyle, David B Freeman, et al.

Cancer Discovery|March 20, 2021

ZFTA-RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial EpendymomaAmir Arabzade, Yanhua Zhao, Srinidhi Varadharajan, et al.

Pageof 5

Search research articles

Showing results (41-50 of 44) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 44 results.

Nature|September 3, 2015

The spliceosome is a therapeutic vulnerability in MYC-driven cancerTiffany Y-T Hsu, Lukas M Simon, Nicholas J Neill, et al.

Cell|January 15, 2021

Spliceosome-targeted therapies trigger an antiviral immune response in triple-negative breast cancerElizabeth A Bowling, Jarey H Wang, Fade Gong, et al.

Cell Chemical Biology|October 21, 2020

Modulating Androgen Receptor-Driven Transcription in Prostate Cancer with Selective CDK9 InhibitorsAndré Richters, Shelby K Doyle, David B Freeman, et al.

Cancer Discovery|March 20, 2021

ZFTA-RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial EpendymomaAmir Arabzade, Yanhua Zhao, Srinidhi Varadharajan, et al.

Pageof 5